Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

'Low ticket sales'
Impaled by umbrella
Under house arrest
Right-only dating app
FBI office shoot-out
Doorbell camera show
Jet skims spectators
Killed by leg bomb
Father of her kids?
'Parasite' apts. ban
Roller coaster crash
Tree victims ID'd
Informant tip-off
F-bombs heckler
Let boy, 6, drink?
40% more lead in eggs
Fights for coyote
CEO's sad selfie
Noticed it breathing
Homemade just as toxic
'So open' to reprise
87-homes-for-1 error
Jokes about hit price
Dispute over rockets
Collapses in NY heat
Postage price hike
Own chatbot criticizes
Tax credit worry
Earth gas in moon rock
Reopening in Ukraine
Sea sponges sneeze
New most valuable card
Non-intentional doping
'ISIS Beatle' charged
Last supermoon of 2022
Methane super emitters
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
10,700 results
BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October
BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...
UPI.com on MSN.com
2d
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...
Forbes on MSN.com
3d
COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October
BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...
Washington Examiner on MSN.com
2d
Pfizer and BioNTech say updated Covid-19 boosters show increased immune response against Omicron variant
Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday.
KESQ News1mon
Pfizer, BioNTech to study 'bivalent' booster as FDA weighs approach
The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...
BioPharma Dive
15d
U.S. to Offer Updated COVID Booster Shots in September
The Biden administration plans to begin a COVID-19 booster campaign with reformulated vaccines in September. The new boosters ...
WebMD
8d
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
We need vaccines with longer duration and greater breadth of protection,' said Dr. David Kessler, chief science officer for ...
MarketWatch on MSN.com
13d
Pfizer, BioNTech say updated vaccines offer ‘substantially higher immune response’ against omicron
Pharmaceutical and biotechnology companies Pfizer and BioNTech announced Saturday that updated versions of their ... Studies “found that a booster dose of both Omicron-adapted vaccine candidates ...
MSN1mon
UPDATE 2-BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...
YAHOO!Finance
3d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
This is the first of multiple vaccine candidates with an enhanced design which the companies plan to evaluate as part of a long-term scientific COVID-19 vaccine strategy to potentially generate more ...
Associated Press
15d
BioNTech Announces Second Quarter Financial Results and Corporate Update
Second quarter revenues of EUR3.2 billion1, net profit of EUR1.7 billion and fully diluted earnings per share of EUR6.45 ($6.872) as well as first half ...
MarketWatch
3d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation ...
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...
The Bakersfield Californian
15d
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback